Jan 14 2022 Reviewed by Danielle Ellis, B.Sc. Bedford, UK | 13th January 2022 – MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta, and Gamma variants of the COVID-19 virus. MIP Diagnostics, the leading manufacturer of molecularly imprinted...
